Why the study?
How should multi-modality imaging be used in the diagnosis, family screening, follow-up, risk assessment, and differential diagnosis of arrhythmogenic cardiomyopathy?
Population
Patients with arrhythmogenic cardiomyopathy (AC) and their families undergoing screening
Design
Guideline
Authors
Loading...
Standardizes multi-modality imaging for arrhythmogenic cardiomyopathy diagnosis and risk assessment; extends expert consensus to guide practice and future studies.
How should multi-modality imaging be used in the diagnosis, family screening, follow-up, risk assessment, and differential diagnosis of arrhythmogenic cardiomyopathy?
This expert consensus document provides standardized clinical recommendations for utilizing multi-modality imaging in the diagnosis, risk assessment, and follow-up of arrhythmogenic cardiomyopathy.
Haugaa et al. (2016) conducted a review in Arrhythmogenic cardiomyopathy. Multi-modality imaging was evaluated. Multi-modality imaging recommendations for the diagnosis, family screening, follow-up, and risk assessment of arrhythmogenic cardiomyopathy are provided in this expert consensus document.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: